Total Funding
32
7
Total FundingVenture - Series Unknown raised
Growth Score
-2 pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
647977
A precise, natural, sustainable treatment that aids wound bed preparation towards wound healing.
Gareth Kempson: Chief Executive Officer
About the Company
BioMonde is a European wound care company specialising in the manufacture and distribution of larval debridement therapy (also known as maggot therapy) products for use in chronic and hard to heal wounds. Our state of the art pharmaceutical production units in the UK and Germany, together with our commitment to research, development and education,
make BioMonde the first choice in wound debridement.
